Shangya Technology Co., Ltd. (TPEX:6130)

Market Cap	1.75B +72.1%
Revenue (ttm)	159.78M -22.6%
Net Income	-76.26M
EPS	-1.72
Shares Out	44.30M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	494,741
Average Volume	267,159
Open	37.35
Previous Close	37.05
Day's Range	36.80 - 39.50
52-Week Range	21.10 - 48.30
Beta	0.14
RSI	43.57
Earnings Date	Mar 24, 2026

About Shangya Technology

Shangya Technology Co., Ltd. engages in the generic drugs and solar power generation businesses in Taiwan and Asia. The company wholesales Chinese and Western medicines, medical equipment, and beauty and hair care products; and onrito, lixin fumitation, lufuxing film-coated, amperex film coating, leverb-coated, triton film-coated, special core stabilized, tanlipo film-coated, inhibitory film-coated, yoyo flat mouth dissolved, and binlishu film-coated tablet, as well as pain relief capsules and yue shi tong injection. It is also involved in the ...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1994
• Employees: 31
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 6130

Financial Performance

In 2024, Shangya Technology's revenue was 195.35 million, a decrease of -15.47% compared to the previous year's 231.12 million. Losses were -33.43 million, -58.24% less than in 2023.